Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
Clinical trial NCT01942213 · COMPLETED
Trial details
- NCT number
- NCT01942213
- Sponsor
- Prism Vision Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.